2018
Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial
Edelman EJ, Moore BA, Holt SR, Hansen N, Kyriakides TC, Virata M, Brown ST, Justice AC, Bryant KJ, Fiellin DA, Fiellin LE. Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial. AIDS And Behavior 2018, 23: 211-221. PMID: 30073637, PMCID: PMC6476298, DOI: 10.1007/s10461-018-2241-z.Peer-Reviewed Original ResearchConceptsHIV-positive patientsHeavy drinking daysVACS Index scoreXR-NTXART adherenceDrinking daysIndex scoreUndetectable HIV viral loadCD4 cell countExtended-release naltrexoneDouble-blind placeboHIV viral loadRandomized-controlled trialDrinking outcomesHIV biomarkersSecondary outcomesHIV outcomesPrimary outcomeViral loadAntiretroviral adherenceClinical trialsCell countAlcohol treatmentHIVPatients
2015
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients
Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ, Gaither J, Gordon AJ, Goulet J, Kerns RD, Moore BA, Tate J, Justice AC, Fiellin DA. Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2015, 69: 223-233. PMID: 26009831, PMCID: PMC4446730, DOI: 10.1097/qai.0000000000000591.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidAnti-Retroviral AgentsBenzodiazepinesCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedProspective StudiesSurvival AnalysisConceptsLong-term opioidsMorphine equivalent daily doseOpioid receiptRisk of deathLong-term prescriptionUninfected patientsOpioid dosesAntiretroviral therapyHazard ratioDaily dosePropensity scoreHigher opioid dosesCause mortalityHIV statusAvailable patientsMortality riskOpioidsHIVPatientsProspective analysisMortalityBenzodiazepinesDosesDeathRiskA Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV
Moore BA, Rosen MI, Wang Y, Shen J, Ablondi K, Sullivan A, Guerrero M, Siqueiros L, Daar ES, Liu H. A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV. AIDS And Behavior 2015, 19: 156-162. PMID: 25645326, PMCID: PMC4498993, DOI: 10.1007/s10461-014-0990-x.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Retroviral AgentsCaliforniaCognitive Behavioral TherapyDirective CounselingFeasibility StudiesFemaleHIV InfectionsHumansMaleMedication AdherenceMotivationPatient Acceptance of Health CareProgram EvaluationSubstance Abuse, IntravenousSubstance-Related DisordersTelephoneTreatment OutcomeYoung AdultConceptsAntiretroviral therapyContingency managementContingency management therapyBehavior therapy sessionsHIV patientsMedication adherenceTelephone sessionsPrescribed dosesParticipant adherenceManagement therapyPrior interventionsPromising interventionAlcohol useAdherenceTherapy sessionsHIVPatientsTherapyModest effectCognitive behavior therapy sessionsWeeksInterventionSessionsDosesCare